Topic: Evidence Based Medicine

Evidence Based Medicine comes up in 3 chapters across 3 episodes of The Higherside Chats Free Show, from April 2020 to March 2022.

April 2020 March 2022

Related topics

Dr. Jennifer Daniels | The Lethal Dose, The Standard Of Care, & The Turpentine Truth
• 1:07:12 - 1:10:46

Dr. Jennifer Daniels | The Lethal Dose, The Standard Of Care, & The Turpentine Truth

Expatriation Fears and the Basics of Health Maintenance

Carlwood explores the psychological barriers to leaving the United States, comparing the current social climate to "frogs in boiling water." He reiterates the importance of health basics like hydration and references previous guests who have critiqued the shift toward "evidence-based medicine" as a tool for industry control.

expatriationdana cohenrichard amerlingevidence based medicinehydration
Dr. Richard Amerling | America’s Frontline Doctors, EBM Manipulation, & Covid Corruption
• 15:53 - 18:43

Dr. Richard Amerling | America’s Frontline Doctors, EBM Manipulation, & Covid Corruption

Evidence-Based Medicine Tyranny and Remdesivir Efficacy

Dr. Richard Amerling criticizes the pharmaceutical industry's control over evidence-based medicine (EBM), labeling Remdesivir a "crappy drug" with no impact on mortality. He argues that pharmaceutical companies manipulate data and control the publication process to favor their products. Amerling contends that standardized guidelines create a "one size fits all" tyranny that prevents doctors from using clinical judgment or alternative treatments.

Dr. Andrew Kaufman | Schizophrenia, The COVID-19 Coronavirus, & Exosomes
• 4:01 - 9:19

Dr. Andrew Kaufman | Schizophrenia, The COVID-19 Coronavirus, & Exosomes

Pharmaceutical Industry Bias and Antidepressant Meta-Analysis

Dr. Andrew Kaufman describes his transition from conventional clinical training to a skeptical view of the pharmaceutical industry. He cites a specific Freedom of Information Act request that revealed drug companies often suppress negative trial data when seeking FDA approval. A meta-analysis of these trials suggested that many antidepressants perform no better than placebos, leading Kaufman to reduce his reliance on prescriptions.